- Home
- YSXT vs MNOV Comparison
YSXT vs MNOV Comparison
Compare YSXT & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YSXT | MNOV |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8M | 72.7M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | YSXT | MNOV |
|---|---|---|
| Price | $1.64 | $1.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 306.8K | 73.0K |
| Earning Date | 02-03-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,360,807.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.57 | ★ N/A |
| Revenue Growth | N/A | ★ 194.15 |
| 52 Week Low | $1.03 | $1.13 |
| 52 Week High | $9.90 | $1.96 |
Technical Indicators
Market Signals| Indicator | YSXT | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | 71.05 | 50.67 |
| Support Level | $1.08 | $1.24 |
| Resistance Level | $2.80 | $1.62 |
| Average True Range (ATR) | 0.17 | 0.08 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 77.66 | 65.03 |
Price Performance
Historical ComparisonAbout YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.